Molecular aspects of alcohol metabolism: Transcription factors involved in early ethanol-induced liver injury

Annual Review of Nutrition

Volumn 24, Issue , 2004, Pages 55-78

  Nagy, Laura E ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Fatty liver; Inflammation; Kupffer cells; Signal transduction

Indexed keywords

ALCOHOL; ALCOHOL DEHYDROGENASE; CYTOCHROME P450 2E1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; STEROL REGULATORY ELEMENT BINDING PROTEIN; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR;

ADIPOSE TISSUE; ALCOHOL METABOLISM; CELL ACTIVATION; DISEASE COURSE; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYMOLOGY; FATTY LIVER; GENE EXPRESSION; HEPATITIS; HUMAN; IMMUNE SYSTEM; KUPFFER CELL; LIPID METABOLISM; LIVER FUNCTION; LIVER INJURY; LIVER METABOLISM; MOLECULAR DYNAMICS; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SIGNAL TRANSDUCTION; STEATOSIS;

ALCOHOL DEHYDROGENASE; ALCOHOL DRINKING; CYTOCHROME P-450 CYP2E1; ETHANOL; HUMANS; KUPFFER CELLS; LIVER; LIVER DISEASES, ALCOHOLIC; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

JANUS;

EID: 3142759942     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.24.012003.132258     Document Type: Review

References (144)

1. Adachi Y, Bradford BU, Gao W, Bojes HK, Thurman RG. 1994. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 20:453-60
2. Agarwal DP. 2001. Genetic polymorphisms of alcohol metabolizing enzymes. Pathol. Biol. (Paris) 49:703-9
3. Albano E. 2002. Free radical mechanisms in immune reactions associated with alcoholic liver disease. Free Radic. Biol. Med. 32:110-14
4. Aldred A, Nagy LE. 1999. Ethanol dissociates hormone-stimulated cAMP production from inhibition of TNFα production in rat Kupffer cells. Am. J. Physiol. 276:G98-106
5. Angel P, Karin M. 1991. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072:129-57
6. Armendariz-Borunda J, Simkevich CP, Roy N, Raghow R, Kang AH, Seyer JM. 1994. Activation of Ito cells involves regulation of AP-1 binding proteins and induction of type I collagen gene expression. Biochem. J. 304:817-24
7. Badger TM, Hoog JO, Svensson S, McGehee RE Jr, Fang C, et al. 2000. Cyclic expression of class I alcohol dehydrogenase in male rats treated with ethanol. Biochem. Biophys. Res. Commun. 274:684-88
8. Baek SJ, Wilson LC, Hsi LC, Eling TE. 2003. Troglitazone, a peroxisome proliferator-activated receptor γ (PPARγ) ligand, selectively induces the early growth response-1 gene independently of PPARγ. A novel mechanism for its anti-tumorigenic activity. J. Biol. Chem. 278:5845-53
9. Best CA, Laposata M. 2003. Fatty acid ethyl esters: toxic non-oxidative metabolites of ethanol and markers of ethanol intake. Front. Biosci. 8:e202-17
10. Beutler B. 1995. TNF, immunity and inflammatory disease: lessons of the past decade. J. Investig. Med. 43:227-35
11. Bode C, Kugler V, Bode JC. 1987. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J. Hepatol. 4:8-14
12. Bode C, Schafer C, Fukui H, Bode JC. 1997. Effect of treatment with paromomycin on endotoxemia in patients with alcoholic liver disease - a double-blind, placebo-controlled trial. Alcohol. Clin. Exp. Res. 21:1367-73
13. Boelsterli UA, Bedoucha M. 2002. Toxicological consequences of altered peroxisome proliferator-activated receptor γ (PPARγ) expression in the liver: insights from models of obesity and type 2 diabetes. Biochem. Pharmacol. 63:1-10
14. Bogdan C, Rollinghoff M, Diefenbach A. 2000. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 12:64-76
15. Bowie A, O'Neill LA. 2000. Oxidative stress and nuclear factor-κβ activation: a reassessment of the evidence in the light of recent discoveries. Biochem. Pharmacol. 59:13-23
16. Braddock M. 2001. The transcription factor Egr-1: a potential drug in wound healing and tissue repair. Ann. Med. 33:313-18
17. Brunt EM. 2002. Alcoholic and nonalcoholic steatohepatitis. Clin. Liver Dis. 6:399-420, vii
18. Cao Q, Mak KM, Lieber CS. 2002. Dilinoleoylphosphatidylcholine decreases LPS-induced TNFα generation in Kupffer cells of ethanol-fed rats: respective roles of MAPKs and NFκB. Biochem. Biophys. Res. Commun. 294:849-53
19. Carmichael FJ, Saldivia V, Varghese GA, Israel Y, Orrego H. 1988. Ethanol-induced increase in portal blood flow: role of acetate and A1- and A2-adenosine receptors. Am. J. Physiol. 255:G417-23
20. Chan ED, Riches DW, White CW. 2001. Redox paradox: effect of N-acetylcy steine and serum on oxidation reduction-sensitive mitogen-activated protein kinase signaling pathways. Am. J. Respir. Cell. Mol. Biol. 24:627-32
21. Chen JP, Ishac EJN, Dent P, Kunos G, Gao B. 1998. Effects of ethanol on mitogen-activated protein kinase and stress-activated protein kinase cascades in normal and regenerating liver. Biochem. J. 334:669-76
22. Clarke SD. 2001. Nonalcoholic steatosis and steatohepatitis. I. Molecular mechanism for polyunsaturated fatty acid regulation of gene transcription. Am. J. Physiol. Gastrointest. Liver Physiol. 281:G865-69
23. Daynes RA, Jones DC. 2002. Emerging roles of PPARs in inflammation and immunity. Nat. Rev. Immunol. 2:748-59
24. Desvergne B, Wahli W. 1999. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20:649-88
25. Donohue TM Jr. 2002. The ubiquitin-proteasome system and its role in ethanol-induced disorders. Addict. Biol. 7:15-28
26. Eaton S, Record CO, Bartlett K. 1997. Multiple biochemical effects in the pathogenesis of alcoholic fatty liver. Eur. J. Clin. Invest. 27:719-22
27. Enomoto N, Takei Y, Hirose M, Konno A, Shibuya T, et al. 2003. Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-{γ}, pioglitazone. J. Pharmacol. Exp. Ther. 306:846-54
28. Eriksson CJ. 2001. The role of acetaldehyde in the actions of alcohol (update 2000). Alcohol. Clin. Exp. Res. 25:15S-32S
29. Fischer M, You M, Matsumoto M, Crabb DW. 2003. Peroxisome proliferator-activated receptor α (PPARα) agonist treatment reverses PPARa dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. J. Biol. Chem. 278:27997-8004
30. Franks NP, Lieb WR. 1994. Molecular and cellular mechanisms of general anaesthesia. Nature 367:607-14
31. Fukui H, Brauner B, Bode J, Bode C. 1991. Plasma endotoxin concentrations in patients with alcoholic and nonalcoholic liver disease: reevaluation with an improved chromogenic assay. J. Hepatol. 12:162-69
32. Galli A, Pinaire J, Fischer M, Dorris R, Crabb DW. 2001. The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor α is inhibited by ethanol metabolism. A novel mechanism for the development of ethanol-induced fatty liver. J. Biol. Chem. 276:68-75
33. Gashler A, Sukhatme VP. 1995. Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog. Nucleic Acid. Res. Mol. Biol. 50:191-224
34. Gavrilova O, Haluzik M, Matsusue K, Cutson JJ, Johnson L, et al. 2003. Liver peroxisome proliferator-activated receptor γ contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J. Biol. Chem. 278:34268-76
35. Gregoire FM, Zhang Q, Smith SJ, Tong C, Ross D, et al. 2002. Diet-induced obesity and hepatic gene expression alterations in C57BL/6J and ICAM-1-deficient mice. Am. J. Physiol. Endocrinol. Metab. 282:E703-13
36. Gressner AM, Bachem MG. 1995. Molecular mechanisms of liver fibrogenesis - a homage to the role of activated fat-storing cells. Digestion 56:335-46
37. Guha M, O'Connell MA, Pawlinski R, Hollis A, McGovern P, et al. 2001. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor a expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 98:1429-39
38. Harada S, Agarwal DP, Nomura F, Higuchi S. 2001. Metabolic and ethnic determinants of alcohol drinking habits and vulnerability to alcohol-related disorder. Alcohol. Clin. Exp. Res. 25:71S-75S
39. Hill DB, Devalaraja R, Joshi-Barve S, Barve S, McClain CJ. 1999. Antioxidants attenuate nuclear factor-κβ activation and tumor necrosis factor-α production in alcoholic hepatitis patient monocytes and rat Kupffer cells, in vitro. Clin. Biochem. 32:563-70
40. Hoek JB, Pastorino JG. 2002. Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol 27:63-68
41. Horton JD, Goldstein JL, Brown MS. 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109:1125-31
42. Horton JD, Shimomura I. 1999. Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis. Curr. Opin. Lipidol. 10:143-50
43. Horton JD, Shimomura I, Ikemoto S, Bashmakov Y, Hammer RE. 2003. Overexpression of SREBP-1a in mouse adipose tissue produces adipocyte hypertrophy, increased fatty acid secretion, and fatty liver. J. Biol. Chem. 278:36652-60
44. Ide T, Shimano H, Yoshikawa T, Yahagi N, Amemiya-Kudo M, et al. 2003. Crosstalk between peroxisome proliferator-activated receptor (PPAR) α and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling. Mol. Endocrinol. 17:1255-67
45. Iles K, Nagy LE. 1995. Chronic ethanol feeding increases the quantity of G-proteins in rat liver plasma membranes. Hepatology 21:1154-60
46. Ip E, Farrell GC, Robertson G, Hall P, Kirsch R, Leclercq I. 2003. Central role of PPARα-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology 38:123-32
47. Israel Y, Orrego H, Carmichael FJ. 1994. Acetate-mediated effects of ethanol. Alcohol. Clin. Exp. Res. 18:144-48
48. Jacob CO. 1992. Tumor necrosis factor α in autoimmunity: pretty girl or old witch? Immunol. Today 13[4]:122-25
49. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. 2002. Mechanisms of hepatotoxicity. Toxicol. Sci. 65:166-76
50. Janeway CA Jr, Medzhitov R. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197-216
51. Jarvelainen HA, Fang C, Ingelman-Sundberg M, Lukkari TA, Sippel H, Lindros KO. 2000. Kupffer cell inactivation alleviates ethanol-induced steatosis and CYP2E1 induction but not inflammatory responses in rat liver. J. Hepatol. 32:900-10
52. Jarvelainen HA, Oinonen T, Lindros KO. 1997. Alcohol-induced expression of the CD14 endotoxin receptor protein in rat Kupffer cells. Alcohol. Clin. Exp. Res. 21:1547-51
53. Ji C, Kaplowitz N. 2003. Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 124:1488-99
54. Jokelainen K, Reinke LA, Nanji AA. 2001. NF-κβ activation is associated with free radical generation and endotoxemia and precedes pathological liver injury in experimental alcoholic liver disease. Cytokine 16:36-39
55. Kishore R, Hill JR, McMullen MR, Frenkel J, Nagy LE. 2002. ERK1/2 and Egr-1 contribute to increased TNFα production in rat Kupffer cells after chronic ethanol feeding. Am. J. Phys. 282:G6-G15
56. Kishore R, McMullen MR, Nagy LE. 2001. Stabilization of TNFa mRNA by chronic ethanol: role of A + U rich elements and p38 mitogen activated protein kinase signaling pathway. J. Biol. Chem. 276:41930-37
57. Kitano H, Fukui H, Okamoto Y, Kikuchi E, Matsumoto M, et al. 1996. Role of albumin and high-density lipoprotein as endotoxin-binding proteins in rats with acute and chronic alcohol loading. Alcohol. Clin. Exp. Res. 20:73A-76A
58. Koteish A, Diehl AM. 2001. Animal models of steatosis. Semin. Liver Dis. 21:89-104
59. Koteish A, Yang S, Lin H, Huang X, Diehl AM. 2002. Chronic ethanol exposure potentiates lipopolysaccharide liver injury despite inhibiting Jun N-terminal kinase and caspase 3 activation. J. Biol. Chem. 277:13037-44
60. Kotzka J, Muller-Wieland D, Roth G, Kremer L, Munck M, et al. 2000. Sterol regulatory element binding proteins (SREBP)-1a and SREBP-2 are linked to the MAP-kinase cascade. J. Lipid Res. 41:99-108
61. Lee JY, Ye J, Gao Z, Youn HS, Lee WH, et al. 2003. Reciprocal modulation of toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J. Biol. Chem. 278:37041-51
62. 2 regulates the activation of distinct MAPK pathways. Free Radic. Biol. Med. 33:1121-32
63. Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, et al. 1995. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell Biol. 15:3012-22
64. Lee YJ, Aroor AR, Shukla SD. 2002. Temporal activation of p42/44 mitogen-activated protein kinase and c-Jun N-terminal kinase by acetaldehyde in rat hepatocytes and its loss after chronic ethanol exposure. J. Pharmacol. Exp. Ther. 301:908-14
65. Li J, Hu W, Baldassare JJ, Bora PS, Chen S, et al. 2003. The ethanol metabolite, linolenic acid ethyl ester, stimulates mitogen-activated protein kinase and cyclin signaling in hepatic stellate cells. Life Sci. 73:1083-96
66. Li M, Carpio DF, Zheng Y, Bruzzo P, Singh V, et al. 2001. An essential role of the NF-κβ/toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J. Immunol. 166:7128-35
67. Li XK, Fujino M, Guo L, Okuyama T, Funeshima N, et al. 2000. Inhibition of Fas-mediated fulminant hepatitis in CrmA gene-transfected mice. Biochem. Biophys. Res. Commun. 273:101-9
68. Lieber CS. 1997. Cytochrome P-4502E1: its physiological and pathological role. Physiol. Rev. 77:517-44
69. Lieber CS. 1999. Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968-1998) - a review. Alcohol. Clin. Exp. Res. 23:991-1007
70. Lieber CS. 2000. Alcohol: its metabolism and interaction with nutrients. Annu. Rev. Nutr. 20:395-430
71. Lin HZ, Yang SQ, Chuckaree C, Kuhajda F, Ronnet G, Diehl AM. 2000. Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nature Med. 6:998-1003
72. Lin HZ, Yang SQ, Zeldin G, Diehl AM. 1998. Chronic ethanol consumption induces the production of tumor necrosis factor-α and related cytokines in liver and adipose tissue. Alcohol. Clin. Exp. Res. 22(Suppl.):231S-37S
73. Ling PR, Bistrian BR, Mendez B, Istfan NW. 1994. Effects of systemic infusions of endotoxin, tumor necrosis factor, and interleukin-1 on glucose metabolism in the rat: relationship to endogenous glucose production and peripheral tissue glucose uptake. Metabolism 43:279-84
74. Martinez-Hernandez A, Amenta PS. 1993. The hepatic extracellular matrix II. Ontogenesis, regeneration and cirrhosis. Virchows Archiv. A Pathol. Anat. 423:77-84
75. Masamune A, Kikuta K, Satoh M, Satoh A, Shimosegawa T. 2002. Alcohol activates activator protein-1 and mitogen-activated protein kinases in rat pancreatic stellate cells. J. Pharmacol. Exp. Ther. 302:36-42
76. McClain CJ, Hill DB, Song Z, Deaciuc I, Barve S. 2002. Monocyte activation in alcoholic liver disease. Alcohol 27:53-61
77. Memon RA, Tecott LH, Nonogaki K, Beigneux A, Moser AH, et al. 2000. Up-regulation of peroxisome proliferator-activated receptors (PPAR-α) and PPAR-γ messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-γ-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology 141:4021-31
78. Mottaran E, Stewart SF, Rolla R, Vay D, Cipriani V, et al. 2002. Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease. Free Radic. Biol. Med. 32:38-45
79. Muller M, Kersten S. 2003. Nutrigenomics: goals and strategies. Nat. Rev. Genet. 4:315-22
80. Nagy LE. 1992. Ethanol metabolism and inhibition of nucleoside uptake lead to increased extracellular adenosine in hepatocytes. Am. J. Physiol. 262:C1175-80
81. Nagy LE. 2003. Recent insights into the role of the innate immune system in the development of alcoholic liver disease. Exp. Biol. Med. 228:882-90
82. Nagy LE, deSilva SEF. 1992. Ethanol increases receptor-dependent cAMP production in cultured hepatocytes by decreasing Gi-mediated inhibition. Biochem. J. 286:681-86
83. Nagy LE, deSilva SEF. 1994. Adenosine A1 receptors mediate chronic ethanol-induced increases in receptor-stimulated cAMP in cultured hepatocytes. Biochem. J. 304:205-10
84. Nanji AA, Jokelainen K, Rahemtulla A, Miao L, Fogt F, et al. 1999. Activation of nuclear factor κβ and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology 30:934-43
85. Nanji AA, Khettry U, Sadrzadeh SMH, Yamanaka T. 1993. Severity of liver injury in experimental alcoholic liver disease: correlation with plasma endotoxin, prostaglandin E2, leukotriene B4 and thromboxane B2. Am. J. Pathol. 142:367-73
86. Nanji AA, Zhao S, Sadrzadeh SM, Dannenberg AJ, Tahan SR, Waxman DJ. 1994. Markedly enhanced cytochrome P450 2E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-ethanol-fed rats. Alcohol. Clin. Exp. Res. 18:1280-85
87. Niemela O, Juvonen T, Parkkila S. 1991. Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption. J. Clin. Invest. 87:1367-74
88. O'Neill LAJ. 2002. Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal? Trends Immunol. 23:296-300
89. Okada M, Yan SF, Pinsky DJ. 2002. Peroxisome proliferator-activated receptor-γ (PPAR-γ) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets. FASEB J. 16:1861-68
90. Onishi Y, Honda M, Ogihara T, Sakoda H, Anai M, et al. 2003. Ethanol feeding induces insulin resistance with enhanced PI 3-kinase activation. Biochem. Biophys. Res. Commun. 303:788-94
91. Orrego H, Carmichael FJ, Saldvia V, Giles HG, Sandrin S, Israel Y. 1988. Ethanol-induced increase in portal blood flow: role of adenosine. Am. J. Physiol. 254:G495-501
92. Osna NA, Clemens DL, Donohue TM. 2003. Interferon gamma enhances proteasome activity in recombinant Hep G2 cells that express cytochrome P4502E1: modulation by ethanol. Biochem. Pharmacol. 66:697-710
93. Paradis V, Kollinger M, Fabre M, Holstege A, Poynard T, Bedossa P. 1997. In situ detection of lipid peroxidation by-products in chronic liver diseases. Hepatology 26:135-42
94. Parlesak A, Schafer C, Schutz T, Bode JC, Bode C. 2000. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J. Hepatol. 32:742-47
95. Peoples RW, Li C, Weight FF. 1996. Lipid vs protein theories of alcohol action in the nervous system. Annu. Rev. Pharmacol. Toxicol. 36:185-201
96. Pickup JC, Chusney GD, Thomas SM, Burt D. 2000. Plasma interleukin-6, tumour necrosis factor a and blood cytokine production in type 2 diabetes. Life Sci. 67:291-300
97. Poirier LA, Rachdaoui N, Nagy LE. 2001. GLUT4 vesicle trafficking in rat adipocytes after ethanol feeding: regulation by heterotrimeric G-proteins. Biochem. J. 354:323-30
98. Raghow R. 1994. The role of extracellular matrix in postinflammatory wound healing and fibrosis. FASEB J. 8:823-31
99. Rahimian R, Masih-Khan E, Lo M, van Breemen C, McManus BM, Dube GP. 2001. Hepatic over-expression of peroxisome proliferator activated receptor γ2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus. Mol. Cell Biochem. 224:29-37
100. Ramchandani VA, Bosron WF, Li TK. 2001. Research advances in ethanol metabolism. Pathol. Biol. (Paris) 49:676-82
101. Reddy JK. 2001. Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR α, and steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 281:G1333-39
102. Román J, Colell A, Blasco C, Caballeria J, Parés A, et al. 1999. Differential role of ethanol and acetaldehyde in the induction of oxidative stress in HEP G2 cells: effect on transcription factors AP-1 and NF-κβ. Hepatology 30:1473-80
103. Roth G, Kotzka J, Kremer L, Lehr S, Lohaus C, et al. 2000. MAP kinases Erk1/2 phosphorylate sterol regulatory element-binding protein (SREBP)-1a at serine 117 in vitro. J. Biol. Chem. 275:33302-7
104. Salaspuro MP, Shaw S, Jayatilleke E, Ross WA, Lieber CS. 1981. Attenuation of the ethanol-induced hepatic redox change after chronic alcohol consumption in baboons: metabolic consequences in vivo and in vitro. Hepatology 1:33-38
105. Sampey BP, Korourian S, Ronis MJ, Badger TM, Petersen DR. 2003. Immunohistochemical characterization of hepatic malondialdehyde and 4-hydroxynonenal modified proteins during early stages of ethanol-induced liver injury. Alcohol. Clin. Exp. Res. 27:1015-22
106. Sasaki Y, Wands JR. 1994. Ethanol impairs insulin receptor substrate-1 mediated signal transduction during rat liver regeneration. Biochem. Biophys. Res. Comm. 199:403-9
107. Sethi JK, Hotamisligil GS. 1999. The role of TNFα in adipocyte metabolism. Semin. Cell Dev. Biol. 10:19-29
108. Shi L, Kishore R, McMullen M, Nagy LE. 2002. Chronic ethanol increases LPS-stimulated Egr-1 expression in RAW 264.7 macrophages: contribution to enhanced TNFa production. J. Biol. Chem. 277:14777-85
109. Shimano H, Horton JD, Hammer RE, Shimomura I, Brown MS, Goldstein JL. 1996. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J. Clin. Invest. 98:1575-84
110. Shimano H, Horton JD, Shimomura I, Hammer RE, Brown MS, Goldstein JL. 1997. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J. Clin. Invest. 99:846-54
111. Shimomura I, Bashmakov Y, Horton JD. 1999. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J. Biol. Chem. 274:30028-32
112. Shimomura I, Bashmakov Y, Ikemoto S, Horton JD, Brown MS, Goldstein JL. 1999. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. USA 96:13656-61
113. Shimomura I, Shimano H, Korn BS, Bashmakov Y, Horton JD. 1998. Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J. Biol. Chem. 273:35299-306
114. Slater SJ, Cox KJ, Lombardi JV, Ho C, Kelly MB, et al. 1993. Inhibition of protein kinase C by alcohols and anaesthetics. Nature 364:82-84
115. Smith SA. 2002. Peroxisome proliferator-activated receptors and the regulation of mammalian lipid metabolism. Biochem. Soc. Trans. 30:1086-90
116. Spolarics Z. 1998. Endotoxemia, pentose cycle, and the oxidant/antioxidant balance in the hepatic sinusoid. J. Leukocyte Biol. 63:534-41
117. Stefan N, Stumvoll M. 2002. Adiponectin - its role in metabolism and beyond. Horm. Metab. Res. 34:469-74
118. Stern M, Carter EA, Walker WA. 1986. Food proteins and gut mucosal barrier. IV. Effects of acute and chronic ethanol administration on handling and uptake of bovine serum albumin by rat small intestine. Dig. Dis. Sci. 31:1242-48
119. Su GL, Rahemtulla A, Thomas P, Klein RD, Wang SC, Nanji AA. 1998. CD14 and lipopolysaccharide binding protein expression in a rat model of alcoholic liver disease. Am. J. Pathol. 152:841-49
120. Szabo G. 2000. New insights into the molecular mechanisms of alcoholic hepatitis: a potential role for NF-κβ activation? J. Lab. Clin. Med. 135:367-69
121. Thurman RG. 1998. Mechanisms of hepatic toxicity II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am. J. Physiol. 275:G605-11
122. Tilg H, Diehl AM. 2000. Cytokines in alcoholic and nonalcoholic steatohepatitis. N. Engl. J. Med. 343:1467-76
123. Tsai EY, Falvo JV, Tsytsykova AV, Barczak AK, Reimold AM, et al. 2000. A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1 and CREB binding protein and p300 is recruited to the tumor necrosis factor a promoter in vivo. Mol. Cell Biol. 20:6084-94
124. Tsukamoto H. 1999. Cytokine regulation of hepatic stellate cells in liver fibrosis. Alcohol. Clin. Exp. Res. 23:911-16
125. Tsukamoto H, Lin M, Ohata M, Giulivi C, French SW, Brittenham G. 1999. Iron primes hepatic macrophages for NF-κβ activation in alcoholic liver injury. Am. J. Physiol. Gastrointest. Liver Physiol. 277:G1240-50
126. Tuma DJ. 2002. Role of malondialdehyde-acetaldehyde adducts in liver injury. Free Radic. Biol. Med. 32:303-8
127. Uesugi T, Froh M, Arteel GE, Bradford BU, Gabele E, et al. 2001. Delivery of Iκβ superrepressor gene with adenovirus reduces early alcohol-induced liver injury in rats. Hepatology 34:1149-57
128. Urbaschek R, McCuskey RS, Rudi V, Becker KP, Stickel F, et al. 2001. Endotoxin, endotoxin-neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease. Alcohol. Clin. Exp. Res. 25:261-68
129. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. 1997. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389:610-14
130. Vidal-Puig A, Jimenez-Linan M, Lowell BB, Hamann A, Hu E, et al. 1996. Regulation of PPARγ gene expression by nutrition and obesity in rodents. J. Clin. Invest. 97:2553-61
131. Vidali M, Stewart SF, Rolla R, Daly AK, Chen Y, et al. 2003. Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver disease. Hepatology 37:410-19
132. Wan YJ, Morimoto M, Thurman RG, Bojes HK, French SW. 1995. Expression of the peroxisome proliferator-activated receptor gene is decreased in experimental alcoholic liver disease. Life Sci. 56:307-17
133. Wang XD, Liu C, Chung J, Stickel F, Seitz HK, Russell RM. 1998. Chronic alcohol intake reduces retinoic acid concentration and enhances AP-1 (c-Jun and c-Fos) expression in rat liver. Hepatology 28:744-50
134. Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, et al. 2001. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J. Clin. Invest. 107:1263-73
135. Wheeler MD, Thurman RG. 2003. Upregulation of CD14 in liver due to acute ethanol involves oxidant-dependent AP-1 pathway. J. Biol. Chem. 278:8345-51
136. Wilkemeyer MF, Sebastian AB, Smith SA, Charness ME. 2000. Antagonists of alcohol inhibition of cell adhesion. Proc. Natl. Acad. Sci. USA 97:3690-95
137. Wilkes JJ, DeForrest LL, Nagy LE. 1996. Chronic ethanol feeding in a high-fat diet decreases insulin-stimulated glucose transport in rat adipocytes. Am. J. Physiol. 271:E477-84
138. Wilkes JJ, Nagy LE. 1996a. Chronic ethanol feeding impairs glucose tolerance but does not produce skeletal muscle insulin resistance in rat epitrochlearis muscle. Alcohol. Clin. Exp. Res. 20:1016-22
139. Wung BS, Cheng JJ, Chao YJ, Hsieh HJ, Wang DL. 1999. Modulation of Ras/Raf/ extracellular signal-regulated kinase pathway by reactive oxygen species is involved in cyclic strain-induced early growth response-1 gene expression in endothelial cells. Circ. Res. 84:804-12
140. Xiong S, She H, Sung CK, Tsukamoto H. 2003. Iron-dependent activation of NF-κβ in Kupffer cells: a priming mechanism for alcoholic liver disease. Alcohol 30:107-13
141. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. 2003. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J. Clin. Invest. 112:91-100
142. Yan SF, Fujita T, Lu J, Okada K, Zou YS, et al. 2000. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nature Med. 6:1355-61
143. You M, Fischer M, Deeg MA, Crabb DW. 2002. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J. Biol. Chem. 217:29342-41
144. Yu S, Matsusue K, Kashireddy P, Cao WQ, Yeldandi V, et al. 2003. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor γ1 (PPARγ1) overexpression. J. Biol. Chem. 278:498-505